pipeline zymeworks

  • Zymeworks Inc. | LinkedIn

    Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged ...

    Get price
  • MSD | Research | Pipeline

    Jul 31, 2020· While this pipeline chart remains on the company's website the company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the presentation and investors should not rely upon the information as current or accurate after May 1, 2020.

    Get price
  • 3 Canadian Biotechs to Consider Buying Today | The Motley Fool

    Feb 07, 2020· A review of Zymeworks' pipeline shows a long list of drug candidates being developed in collaboration with other companies. These include pharma stalwarts Eli Lilly, Merck, ...

    Get price
  • Zymeworks to Present at Upcoming Investor Conferences ...

    Sep 03, 2020· Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged ...

    Get price
  • Zymeworks Inc. - Product Pipeline Review - 2015

    Zymeworks Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Zymeworks Inc. - Product Pipeline Review - 2015', provides an overview of the Zymeworks Inc.'s pharmaceutical research and development focus.

    Get price
  • Zymeworks Announces New Multispecific Antibody ...

    Jul 08, 2020· Zymeworks' second clinical candidate, ZW49, is a bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the .

    Get price
  • Regeneron Pharmaceutical's Research and Development Pipeline

    Aug 07, 2020· Our unique ability to repeatedly and consistently translate science into medicine has led to a robust pipeline of clinical-stage medicines, all of which were discovered in our laboratories. Our investigational treatments target allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious ...

    Get price
  • Zymeworks Reports 2020 Second Quarter Financial Results ...

    Aug 05, 2020· Zymeworks plans to initiate its second registration-enabling study for zanidatamab as first line treatment for advanced HER2+ GEA. ... Zymeworks is also advancing a deep preclinical pipeline .

    Get price
  • Zymeworks Announces Agreement with Pfizer and Initiation ...

    Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies.

    Get price
  • Product Pipeline | Product Portfolio | BeiGene

    VIDAZA ® (azacitidine for injection) is a pyrimidine nucleoside analog that has been shown to reverse the effects of DNA hypermethylation and promote subsequent gene re-expression. VIDAZA ® was approved in China in 2017 for the treatment of intermediate-2 and high-risk myelodysplastic syndromes, or MDS, chronic myelomonocyte leukemia, or CMML, and acute myeloid leukemia, or AML, with 20% to ...

    Get price
  • Pipeline - Agenus

    PIPELINE. We are targeting multiple mechanisms to fight cancer with single agent and combination therapies. Click an individual product to view a detailed description. Agenus fully-owned programs. Partnered programs. Partnered option programs. Mechanism/Target Product Partner Preclinical Ph1 Ph2 Ph3 Filed Approved

    Get price
  • Zymeworks | VentureRadar

    Zymeworks is focused on growing its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. More information on Zymeworks can be found at VentureRadar Research / Company Website

    Get price
  • Our Pipeline: Overview - ObsEva

    ObsEva is advancing a pipeline of orally administered, clinical-stage innovative compounds to treat women's reproductive health conditions. Our Pipeline. Overview. ObsEva is advancing three product candidates through clinical development across a total of .

    Get price
  • Pipeline - R&D - Daiichi Sankyo

    Pipeline Chart. To satisfy unmet medical needs, we focus our resources on our priority therapeutic areas of cardiovascular-metabolics and oncology to deliver innovative products that enhance the lives of millions of people around the world. * As of July 2020 read more ...

    Get price
  • Zymeworks Reports 2020 First Quarter Financial Results | T ...

    May 13, 2020· Before joining Zymeworks he held various international commercial leadership roles with Procter & Gamble Pharmaceuticals, Bristol Myers Squibb, and most recently at Amgen where he was the Global Product General Manager for Kyprolis® and the early myeloma pipeline. Zymeworks also appointed Dr. Kelvin Neu, Partner at Baker Bros. Advisors LP, to ...

    Get price
  • Upfront notes for reviewers - MSD

    pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

    Get price
  • Zymeworks Announces Corporate Update Webcast and ...

    Jun 30, 2020· Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged ...

    Get price
  • Zymeworks to Present at Upcoming Investor Conferences ...

    Sep 03, 2020· Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For more information, visit

    Get price
  • Zymeworks and BeiGene Announce License and Collaboration ...

    Nov 27, 2018· "Zymeworks' promising candidates ZW25 and ZW49 complement our oncology pipeline and further advance our mission to develop treatments .

    Get price
  • Biotech catalyst calendars and drug pipelines ...

    Before joining Zymeworks he held various international commercial leadership roles with Procter & Gamble Pharmaceuticals, Bristol Myers Squibb, and most recently at Amgen where he was the Global Product General Manager for Kyprolis® and the early myeloma pipeline. Zymeworks also appointed Dr. Kelvin Neu, Partner at Baker Bros. Advisors LP, to ...

    Get price
  • Zymeworks Inc. | LinkedIn

    Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged ...

    Get price
  • Zymeworks Reports 2020 Second Quarter Financial Results ...

    Aug 05, 2020· Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For more information, visit

    Get price
  • Zymeworks Reports 2020 First Quarter Financial Results ...

    May 07, 2020· Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged ...

    Get price
  • Zymeworks to Present at Upcoming Investor Conferences ...

    Sep 03, 2020· Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged ...

    Get price
  • Zymeworks to Present at Upcoming Investor Conferences ...

    Sep 03, 2020· Zymeworks is presenting on Tuesday, September 15, 2020 at 2:30 p.m. ET. ... Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other ...

    Get price
  • Zymeworks : to Present at Upcoming Investor Conferences ...

    Sep 03, 2020· Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For more information, visit

    Get price
  • Diversity and Talent Acquisition Recruiter Job at ...

    Zymeworks is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer.

    Get price
  • BeiGene Pipeline Portfolio

    Apr 23, 2020· Zymeworks. ZW49 (bispecific anti -HER2 ADC) Planned (in Ph1 ex -China by Zymeworks) Asia ex Japan, AU, NZ: Zymeworks. BGB-3245 (B-RAF) Solid tumors. Asia ex-Japan. SpringWorks. 1. SEA-CD70 (anti-CD70) Planned (starting Ph.1 ex -Asia by Seattle Genetics) Asia ex Japan, AU, NZ: Seattle Genetics. DKN-01 + tislelizumab. Trials in GC/GEJ planned ...

    Get price
  • Pipeline - R&D - Daiichi Sankyo

    Pipeline Chart. To satisfy unmet medical needs, we focus our resources on our priority therapeutic areas of cardiovascular-metabolics and oncology to deliver innovative products that enhance the lives of millions of people around the world. * As of July 2020 read more ...

    Get price
  • Pipeline - Agenus

    PIPELINE. We are targeting multiple mechanisms to fight cancer with single agent and combination therapies. Click an individual product to view a detailed description. Agenus fully-owned programs. Partnered programs. Partnered option programs. Mechanism/Target Product Partner Preclinical Ph1 Ph2 Ph3 Filed Approved

    Get price
  • Pipeline - AnaptysBio

    pipeline. imsidolimab (anb019): anti-il-36r development stage & anticipated milestones therapeutic indication commercial rights antibody program discovery preclinical phase 1 phase 2 phase 3 phase 1 data presented at eaaci 2018 gallop: ...

    Get price
  • Zymeworks Announces Updated Single Agent Data for HER2 ...

    Zymeworks is also advancing a deep preclinical pipeline in immuno-oncology and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For more information, visit SOURCE: Zymeworks < Prev; .

    Get price